Skip to Content

Advancements in SLE Management

Professor Anders Bengtsson from Lund University discusses recent progress in treating Systemic Lupus Erythematosus (SLE) at SCR 2023. He highlights the impact of disease activity on organ damage and discusses drug options, including combinations of belimumab, voclosporin, and anifrolumab.

Anders Bengtsson

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top